37662-1053 NDC - ACIDUM LACTICUM

Drug Information

Product NDC: 37662-1053
Proprietary Name: Acidum Lacticum
Non Proprietary Name: Acidum Lacticum
Active Ingredient(s): 6 [hp_C]/1 LACTIC ACID, DL-
Administration Route(s): ORAL
Dosage Form(s): PELLET

Labeler Information

Field Name	Field Value
Labeler Name:	Hahnemann Laboratories, INC.
Product Type:	HUMAN OTC DRUG
FDA Application Number:
Marketing Category:	UNAPPROVED HOMEOPATHIC
Start Marketing Date:	7/27/2022

Package Information

No.	Package Code	Package Description	Billing Unit
1	37662-1053-1	200 PELLET in 1 VIAL, GLASS (37662-1053-1)
2	37662-1053-2	1200 PELLET in 1 BOTTLE, GLASS (37662-1053-2)
3	37662-1053-3	4000 PELLET in 1 BOTTLE, GLASS (37662-1053-3)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	37662-1053	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	HUMAN OTC DRUG	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME	Acidum Lacticum	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAME	Acidum Lacticum	This is the date that the labeler indicates was the start of its marketing of the drug product.
DOSAGE FORM NAME	PELLET	This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
ROUTE NAME	ORAL	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
START MARKETING DATE	7/27/2022	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
MARKETING CATEGORY NAME	UNAPPROVED HOMEOPATHIC	Name of Company corresponding to the labeler code segment of the Product NDC.
LABELER NAME	Hahnemann Laboratories, INC.	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	LACTIC ACID, DL-	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	6
ACTIVE INGRED UNIT	[hp_C]/1

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code

Next Code